Business Services Industry

Advanced Viral Research Corp. announces Monday a research grant to the Mount Sinai School of Medicine in New York

Business Wire, June 12, 1995

MIAMI--(BUSINESS WIRE)--June 12, 1995--Advanced Viral Research Corp. (ADVR) (OTC:ADVR) Monday announced that Dr. Shalom Hirschman, Professor of Medicine of Mt. Sinai School of Medicine, New York, and Director of Mt. Sinai's Division of Infectious Diseases, has accepted a research grant from ADVR for the purpose of investigating the possible anti-viral effects of RETICULOSE, and the mechanism by which RETICULOSE inhibits viral diseases, including the Human Immunodeficiency Virus (HIV) with the objective of developing new treatments for AIDS and other viral diseases.

CONTACT: Advanced Viral Research Corp., Miami

William Bregman, 305/374-4847

COPYRIGHT 1995 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale